PSYK ETF is a ETF series of ETF Series Solutions (series S000072630). Net assets $1.9M as of 2023-02-28. Index fund.
Showing 15 of 27 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Sage Therapeutics Inc | — | $153K | 800.48% |
| Biohaven Ltd | — | $136K | 715.78% |
| Myriad Genetics Inc | — | $134K | 702.20% |
| Intra-Cellular Therapies Inc | — | $132K | 691.40% |
| Jazz Pharmaceuticals PLC | — | $128K | 669.78% |
| GH Research PLC | — | $110K | 578.68% |
| ACADIA Pharmaceuticals Inc | — | $108K | 568.97% |
| H Lundbeck A/S | — | $87K | 455.93% |
| Alkermes PLC | — | $87K | 454.40% |
| H Lundbeck A/S | — | $86K | 449.55% |
| UCB SA | — | $85K | 447.04% |
| Sarepta Therapeutics Inc | — | $84K | 439.05% |
| Denali Therapeutics Inc | — | $70K | 368.18% |
| Biogen Inc | — | $70K | 366.81% |
| Compass Pathways Plc | — | $70K | 365.29% |
| Report date | Net assets |
|---|---|
| 2023-02-28 | $1.9M |
| 2022-11-30 | $2.1M |
| 2022-08-31 | $1.2M |
| 2022-05-31 | $732K |
| 2022-02-28 | $415K |